By Steve Williams and Jiamie Chen | August 15, 2018
Private civil antitrust enforcement in the United States may be on the verge of its biggest change since 1968.
By Hannah Roberts | August 14, 2018
Postal company set to appeal the fine for breaching competition law
New York Law Journal | Analysis
By Shepard Goldfein and Karen Hoffman Lent | August 13, 2018
In their column on Antitrust Trade and Practice, Shepard Goldfein and Karen Hoffman Lent discuss Judge Brett Kavanaugh's doctrinal preferences regarding antitrust law.
The Legal Intelligencer | News
By Max Mitchell | August 13, 2018
The ruling allows Pfizer to proceed with its antitrust lawsuit against J&J on allegations that rebate programs J&J entered into with insurers and hospitals were designed to curb competition.
By Jenna Greene | August 9, 2018
It's one of the quirkier corners of antitrust law: Private plaintiffs can sue to block mergers. But extracting a settlement is another matter.
By Sue Reisinger | August 8, 2018
In the first half of the year, many of the crackdowns happened in Europe, but other jurisdictions such as Australia, Singapore and Egypt saw heightened enforcement as well.
By Jenna Greene | August 7, 2018
Here's a fun experiment: Four big law firms and two smaller ones on Monday could all legitimately claim a win in a billion-dollar antitrust suit. But who was quickest out of the gate to tout the shared victory?
By Ellis Kim | August 1, 2018
The U.S. Justice Department on Monday filed its opening brief in the D.C. Circuit. Here's a look at the Justice Department team fighting to revive its legal challenge to the AT&T-Time Warner merger.
By Meghan Tribe | July 31, 2018
Cadwalader "is poised to be one of the firms that is going to really be in control of the next M&A cycle,” said new partner Joel Mitnick in New York, who was global co-head of Sidley Austin's antitrust group.
The Legal Intelligencer | Commentary
By Carl W. Hittinger and Jeffry W. Duffy | July 27, 2018
For over 20 years, purportedly anticompetitive patent-litigation settlement agreements between rival branded and generic pharmaceutical manufacturers—so-called “reverse payment” or “pay for delay” settlements—have generated numerous private lawsuits and ranked as one of the Federal Trade Commission's top enforcement priorities, with private plaintiffs and the FTC alike claiming such agreements have cost consumers millions of dollars by keeping generic drugs off the market.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law.com celebrates the California law firms and legal departments driving the state's dynamic legal landscape.
The Texas Lawyer honors attorneys and judges who have made a remarkable difference in the legal profession in Texas.
Shift Schedule: Monday-Friday, 9AM-5PMHours Per Week: 35General Responsibilities:Under the supervision of the Director of Legal Services or ...
Shift Schedule: Monday-Friday, 9AM-5PMHours Per Week: 35General Responsibilities:Under the supervision of the Director of Legal Services or ...
Shipman & Goodwin LLP is seeking a attorney to expand our national commercial real estate lending practice. Candidates should have a mi...